Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular disease in diabetes and the cardiometabolic syndrome: Focus on minority women

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Diabetes and the cardiometabolic syndrome (CMS) are evolving as global epidemics. In the United States, diabetes affects 20 million people, with 47 million afflicted with the CMS. These disorders have a higher propensity for women, particularly in minority populations with disproportionate increase in cardiovascular disease (CVD) morbidity and mortality. Despite the decline in CVD mortality rates in the general population over the past 35 years parallel to the advances in therapeutic interventions, these rates have increased in women with diabetes. Early preventive measures for CVD risk factor through behavioral and lifestyle modification, smoking cessation, and reduction in psychosocial stressors, as well as pharmacotherapy, are among the currently supported approaches to CVD risk reduction in this high-risk population. In this article, we discuss CVD in people with diabetes and the CMS, with emphasis on minority women, a particularly vulnerable population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Centers for Disease Control and Prevention, National Centers for Health Statistics: Women and Cardiovascular Diseasesstatistics 2005. Available at http://www.americanheart.org/ downloadable/heart/1109000876764FS10WM05REV.DOC. Accessed February 5, 2005. A thorough guide on the statistics of CVD in women from several racial and ethnic groups, including comparison between these different groups. It offers clear and accurate tables and figures, describing prevalence of and mortality from various CVD risk factors, CVD types, and overall CVD.

  2. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356–359.

    Article  PubMed  Google Scholar 

  3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.

    Article  Google Scholar 

  4. Grundy SM, Cleeman JI, Merz CN, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004, 24:e149-e161.

    Article  PubMed  CAS  Google Scholar 

  5. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998, 15:539–553.

    Article  PubMed  CAS  Google Scholar 

  6. El-Atat F, Aneja A, Mcfarlane S, Sowers J: Obesity and hypertension. Endocrinol Metab Clin North Am 2003, 32:823–854. A very thorough review of the maladaptive cardiovascular and metabolic responses to obesity in the CMS, with a focus on obesityrelated hypertension, including the pathophysiology and treatment of this entity.

    Article  PubMed  CAS  Google Scholar 

  7. Sowers JR: Recommendations for special populations: diabetes mellitus and the metabolic syndrome. Am J Hypertens 2003, 16:41–45.

    Article  Google Scholar 

  8. Shaw JE, Chisholm DJ: Epidemiology and prevention of type 2 diabetes and the metabolic syndrome. Med J Aust 2003, 179:379–383.

    PubMed  Google Scholar 

  9. Grace SL, Fry R, Cheung A, Stewart DE: Cardiovascular disease. BMC Womens Health 2004, 4(suppl 1):S15.

    Article  PubMed  Google Scholar 

  10. Diabetes and Cardiovascular Disease: report from session held in conjunction with American Diabetes Association 63rd Scientific Sessions [no authors listed]. Endocrinologist 2003, 13:S3.

  11. Ferdinand KC, Clark LT: The epidemic of diabetes mellitus and the metabolic syndrome in African Americans. Rev Cardiovasc Med 2004, 5:528–533.

    Google Scholar 

  12. Castro JP, El-Atat FA, McFarlane SI, et al.: Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep 2003, 5:393–401.

    PubMed  Google Scholar 

  13. Greenlund KJ, Giles WH, Keenan NL, et al.: Prevalence of multiple cardiovascular disease risk factors among women in United States, 1992 and 1995: the behavioral factor surveillance system. J Womens Health 1998, 7:1125–1133.

    Article  PubMed  CAS  Google Scholar 

  14. Sorelle R: Cardiovascular disease rates in women with diabetes. Circulation 2001, 104:e9044.

    PubMed  CAS  Google Scholar 

  15. Coulston AM: Cardiovascular disease risk in women with diabetes needs attention. Am J Clin Nutr 2004, 79:931–932.

    PubMed  CAS  Google Scholar 

  16. Ho JE, Paultre F, Mosca L: Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Stroke 2003, 34:2812–2816.

    Article  PubMed  Google Scholar 

  17. Winkleby MA, Kraemer HC, Ahn DK, Varady AN: Ethnic and socioeconomic differences in cardiovascular disease risk factors. JAMA 1998, 260:356–362.

    Article  Google Scholar 

  18. Birnbaum H, Leong S, Kabra A: Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence. Womens Health Issues 2003, 13:204–213.

    Article  PubMed  Google Scholar 

  19. Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiol Rev 1994, 74:761–811.

    PubMed  CAS  Google Scholar 

  20. Zhang R, Reisin E: Obesity-hypertension: the effects on cardiovascular and renal systems. Am J Hypertens 2000, 13:1308–1314.

    Article  PubMed  CAS  Google Scholar 

  21. Reavan GM: Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annu Rev Med 1993, 44:121–131.

    Article  Google Scholar 

  22. Rocchini AP: Obesity hypertension. Am J Hypertens 2002, 15:50S-52S.

    Article  PubMed  Google Scholar 

  23. Sowers JR: Obesity as a cardiovascular risk factor. Am J Med 2003, 115(suppl 8A):37S-41S.

    Article  PubMed  CAS  Google Scholar 

  24. Hall JE, Hildebrandt DA, Kuo J: Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001, 14:103S-115S. A rich and interesting paper on the role of leptin in the CMS. It elaborates on the elevation of leptin levels in obese subjects and its importance in enhancing sympathetic nervous system activity and, thus, elevated BP.

    Article  PubMed  CAS  Google Scholar 

  25. Hall JE, Crook ED, Jones DW, et al.: Mechanisms of obesityassociated cardiovascular and renal disease. Am J Med Sci 2002, 324:127–137.

    Article  PubMed  Google Scholar 

  26. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. J Am Med Assoc 1999, 281:1291–1297.

    Article  CAS  Google Scholar 

  27. McFarlane SI, Jacober SJ, Winer N, et al.: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002, 25:718–723.

    Article  PubMed  Google Scholar 

  28. McFarlane SI, Castro J, Kaur J, et al.: Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to med. J Clin Hypertens (Greenwich) 2005, 7:73–80. Followed a large diabetic cohort from seven centers in four major U.S. cities, including both urban and suburban populations. The investigators examined 2789 patient records for CVD risk factor control, with a focus on minority women. In this study, there was significantly inferior CVD risk factor control in women compared to men with concomitant difference in quality of care given.

    Google Scholar 

  29. Ferrara A, Williamson DF, Karter AJ, et al.: Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes: the translating research into action for Diabetes (TRIAD) study, 2000–2001. Diabetes Care 2004, 27:2974–2976.

    Article  PubMed  Google Scholar 

  30. Mosca L, Appel LJ, Benjamin EJ, et al.: Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol 2004, 43:900–921.

    Article  PubMed  Google Scholar 

  31. El-Atat F, McFarlane SI, Sowers JR: Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep 2004, 6:215–223.

    PubMed  Google Scholar 

  32. El-Atat FA, Stas SN, McFarlane SI, Sowers JR: The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004, 15:2816–2827.

    Article  PubMed  Google Scholar 

  33. McFarlane SI, Shin JJ, Rundek T, Bigger JT: Prevention of type 2 diabetes. Curr Diab Rep 2003, 3:235–241.

    PubMed  Google Scholar 

  34. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group [no authors listed]. Diabetes Care 2000, 23:1619-1629.

Download references

Author information

Authors and Affiliations

  1. Department of Preventive Medicine and Community Health, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 43, 11203, Brooklyn, NY, USA

    Judith H. LaRosa PhD, RN, FAAN

Authors
  1. John Nicasio DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fadi El-Atat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samy I. McFarlane MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Judith H. LaRosa PhD, RN, FAAN
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nicasio, J., El-Atat, F., McFarlane, S.I. et al. Cardiovascular disease in diabetes and the cardiometabolic syndrome: Focus on minority women. Curr Diab Rep 5, 208–213 (2005). https://doi.org/10.1007/s11892-005-0011-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0011-6

Keywords

Search

Navigation